Cooke & Bieler LP decreased its holdings in shares of AMETEK, Inc. (NYSE:AME – Free Report) by 30.9% during the 4th quarter, Holdings Channel.com reports. The fund owned 217,223 shares of the technology company’s stock after selling 97,070 shares during the period. Cooke & Bieler LP’s holdings in AMETEK were worth $39,157,000 as of its most recent filing with the Securities & Exchange Commission.
Other institutional investors and hedge funds have also recently bought and sold shares of the company. Versant Capital Management Inc raised its stake in AMETEK by 3,116.7% during the fourth quarter. Versant Capital Management Inc now owns 193 shares of the technology company’s stock worth $35,000 after acquiring an additional 187 shares during the period. Itau Unibanco Holding S.A. raised its stake in AMETEK by 62.6% during the third quarter. Itau Unibanco Holding S.A. now owns 200 shares of the technology company’s stock worth $34,000 after acquiring an additional 77 shares during the period. AdvisorNet Financial Inc raised its stake in AMETEK by 1,176.5% during the fourth quarter. AdvisorNet Financial Inc now owns 217 shares of the technology company’s stock worth $39,000 after acquiring an additional 200 shares during the period. Geneos Wealth Management Inc. raised its stake in AMETEK by 42.9% during the fourth quarter. Geneos Wealth Management Inc. now owns 233 shares of the technology company’s stock worth $42,000 after acquiring an additional 70 shares during the period. Finally, OFI Invest Asset Management acquired a new stake in AMETEK during the fourth quarter worth about $43,000. Institutional investors and hedge funds own 87.43% of the company’s stock.
Insider Buying and Selling
In related news, Director Steven W. Kohlhagen sold 1,320 shares of the firm’s stock in a transaction that occurred on Monday, March 3rd. The shares were sold at an average price of $189.41, for a total transaction of $250,021.20. Following the completion of the sale, the director now directly owns 22,029 shares in the company, valued at approximately $4,172,512.89. This trade represents a 5.65 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website. 0.61% of the stock is currently owned by insiders.
AMETEK Price Performance
AMETEK (NYSE:AME – Get Free Report) last posted its quarterly earnings data on Tuesday, February 4th. The technology company reported $1.87 EPS for the quarter, beating analysts’ consensus estimates of $1.85 by $0.02. The business had revenue of $1.76 billion for the quarter, compared to analyst estimates of $1.82 billion. AMETEK had a net margin of 19.83% and a return on equity of 16.94%. The business’s revenue for the quarter was up 1.8% on a year-over-year basis. During the same quarter last year, the business earned $1.68 earnings per share. As a group, equities research analysts forecast that AMETEK, Inc. will post 7.15 EPS for the current fiscal year.
AMETEK announced that its Board of Directors has authorized a share buyback program on Friday, February 7th that allows the company to buyback $1.25 billion in shares. This buyback authorization allows the technology company to purchase up to 2.9% of its stock through open market purchases. Stock buyback programs are usually a sign that the company’s board believes its stock is undervalued.
AMETEK Increases Dividend
The firm also recently announced a quarterly dividend, which will be paid on Monday, March 31st. Investors of record on Friday, March 14th will be issued a dividend of $0.31 per share. This represents a $1.24 dividend on an annualized basis and a yield of 0.69%. This is a boost from AMETEK’s previous quarterly dividend of $0.28. The ex-dividend date is Friday, March 14th. AMETEK’s dividend payout ratio (DPR) is presently 20.91%.
Analyst Upgrades and Downgrades
Several equities research analysts recently weighed in on the stock. StockNews.com upgraded shares of AMETEK from a “hold” rating to a “buy” rating in a research note on Sunday. Bank of America upgraded shares of AMETEK from a “neutral” rating to a “buy” rating and raised their price target for the company from $195.00 to $225.00 in a research note on Monday, December 16th. KeyCorp raised their price target on shares of AMETEK from $205.00 to $215.00 and gave the company an “overweight” rating in a research note on Friday, November 22nd. Robert W. Baird dropped their price target on shares of AMETEK from $200.00 to $197.00 and set a “neutral” rating on the stock in a research note on Wednesday, February 5th. Finally, BNP Paribas upgraded shares of AMETEK from a “neutral” rating to an “outperform” rating and set a $210.00 price target on the stock in a research note on Thursday, January 16th. One research analyst has rated the stock with a sell rating, two have assigned a hold rating, eight have assigned a buy rating and one has issued a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $204.67.
Get Our Latest Stock Analysis on AME
AMETEK Profile
AMETEK, Inc manufactures and sells electronic instruments and electromechanical devices in the North America, Europe, Asia, and South America, and internationally. The company's EIG segment offers advanced instruments for the process, aerospace, power, and industrial markets; process and analytical instruments for the oil and gas, petrochemical, pharmaceutical, semiconductor, automation, and food and beverage industries; instruments to the laboratory equipment, ultra-precision manufacturing, medical, and test and measurement markets; power quality monitoring and c devices, uninterruptible power supplies, programmable power and electromagnetic compatibility test equipment, and sensors for gas turbines and dashboard instruments; heavy trucks, instrumentation, and controls for the food and beverage industries; and aircraft and engine sensors, power supplies, embedded computing, monitoring, fuel and fluid measurement, and data acquisition systems for aerospace and defense industry.
Recommended Stories
- Five stocks we like better than AMETEK
- Top Biotech Stocks: Exploring Innovation Opportunities
- How to Protect Your Portfolio When Inflation Is Rising
- 5 discounted opportunities for dividend growth investors
- 3 Tech Stocks Defying Sector Weakness and Thriving in 2025
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- Despite Challenges Novo Nordisk Plans to Crush GLP-1 Competitors
Want to see what other hedge funds are holding AME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for AMETEK, Inc. (NYSE:AME – Free Report).
Receive News & Ratings for AMETEK Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AMETEK and related companies with MarketBeat.com's FREE daily email newsletter.